Evidence map›Paper›PMID 37352605›Full record

ReviewCurrent opinion in chemical biology2023

Chemical biology approaches to uncovering nuclear ROS control.

Junbing Zhang, Liron Bar-Peled

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Junbing ZhangCenter for Cancer Research, Massachusetts General Hospital, Boston MA, USA. Electronic address: jzhang75@mgh.harvard.edu.
Liron Bar-PeledCenter for Cancer Research, Massachusetts General Hospital, Boston MA, USA; Department of Medicine, Harvard Medical School, Boston MA, USA. Electronic address: lbar-peled@mgh.harvard.edu.
Harvard University · USMassachusetts General Hospital · US

Funding

Deciphering the Role of Reductive Stress in Non Small Cell Lung CancerR37CA260062 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Liron Bar-Peled · 2022 to 2026
$1.9M
Mapping druggable co-dependency pathways in NRF2-driven lung cancersR00CA215249 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BAR-PELED, LIRON · 2019 to 2021
$727k
Chemical Proteomic Identification of Druggable Oncogenic Transcription FactorsR21CA256082 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BAR-PELED, LIRON · 2021 to 2023
$620k
Single cell functional dissection of tumor microenviornment-driven drug resistanceR21CA220082 · NCI · DUKE UNIVERSITY · PI WOOD, KRIS C. · 2018 to 2019
$359k
Mapping druggable co-dependency pathways in NRF2-driven lung cancersK99CA215249 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI BAR-PELED, LIRON · 2017 to 2018
$230k
NCI NIH HHS K99 CA215249NCI NIH HHS R00 CA215249NCI NIH HHS R21 CA220082NCI NIH HHS R21 CA256082NCI NIH HHS R37 CA260062
6 · The paper itself

Abstract

Heightened concentrations of reactive metabolites, including reactive oxygen species (ROS), can damage all macromolecules leading to the erosion of cellular fidelity. In this regard, the control of ROS in the nuclues is essential for cellular homeostasis, and dysregulation of nuclear ROS has been attributed to multiple pathologies and the mechanism of action of certain chemotherapies. How nuclear ROS is generated, detoxified and sensed is poorly understood, and stems in part, from a historical lack of tools that allow for its precise generation and detection. Here, we summarize the latest advances in chemical biology inspired approaches that have been developed to study nuclear ROS and highlight how these tools have led to major breakthroughs in understanding its regulation. The continued development and application of chemical biology approaches to understand nuclear ROS promises to unlock fundamental insights into human physiology and disease.

Indexed as

Oxidative StressHumansReactive Oxygen SpeciesReactive Oxygen Species

Identifiers

PMID37352605
PMCPMC10524750
OpenAlexW4381550669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.